Clinical Trials Browser

Phase 2 × NETWORK × Anemia, Refractory, with Excess of Blasts × Clear all

Anemia, Refractory, with Excess of Blasts, Lymphoma, Myeloproliferative Disorders, Leukemia, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT00016419 2015-03-06

S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome

Phase 2 Completed

130 enrolled

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes

NCT00098683 2014-02-13

Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes

Phase 2 Completed

10 enrolled

Classical hematologyMyeloid

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases

Clinical Trials

ACCELERATE

S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome

Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes